The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
Newsweek on MSN10d
People Aren't Using Ozempic 'Responsibly', Says DoctorSome people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
“These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a ...
FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...
CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback